http://www.zibb.com/all/theme/cq/Angiotech+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 11 Nov 2009 00:49:11 GMTWed, 11 Nov 2009 00:49:11 GMT608831http://www.zibb.com/all/theme/cq/Angiotech+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5659985/Angiotech+Pharmaceuticals+Q+net+loss+narrowsAngiotech Pharmaceuticals, a Canadian specialty pharmaceutical and medical device company, has reported a net loss of $7.8 million, or $0.09 per share, for the third quarter ended September 30, 2009, compared to a net loss of $622.38 million, or $7.31 per share, for the third quarter endedhttp://www.zibb.com/article/5659985/Angiotech+Pharmaceuticals+Q+net+loss+narrowsAngiotech Pharmaceuticals IncorporatedWed, 11 Nov 2009 00:49:11 GMThttp://www.prnewswire.com/news-releases/angiotech-pharmaceuticals-announces-commercial-launch-of-the-tan-endoglidetm-endothelium-insertion-system-in-the-united-states-at-the-american-academy-of-ophthalmology-annual-meeting-65764182.htmlAngiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting.http://www.prnewswire.com/news-releases/angiotech-pharmaceuticals-announces-commercial-launch-of-the-tan-endoglidetm-endothelium-insertion-system-in-the-united-states-at-the-american-academy-of-ophthalmology-annual-meeting-65764182.htmlAngiotech Pharmaceuticals IncorporatedFri, 23 Oct 2009 13:00:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/07-23-2009/0005065428&EDATE=and a corresponding shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (collectively, the "Offering Documents").http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/07-23-2009/0005065428&EDATE=Angiotech Pharmaceuticals IncorporatedThu, 23 Jul 2009 20:58:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=148748&full=1Second Quarter 2009 Financial ResultsVANCOUVER, July 6 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the second quarter ended June 30, 2009, on Thursday August 6, 2009 at 11:00 AM ET (8:00 AMhttp://www.biospace.com/news_story.aspx?StoryID=148748&full=1Angiotech Pharmaceuticals IncorporatedMon, 06 Jul 2009 12:00:00 GMThttp://www.topix.net/business/medical-equipment/2009/03/angiotech-pharmaceuticals-inc-announces-license-agreement-withAngiotech Pharmaceuticals, Inc. today announced it has completed an Amended and Restated Distribution and License Agreement with its partner Baxter International Inc.http://www.topix.net/business/medical-equipment/2009/03/angiotech-pharmaceuticals-inc-announces-license-agreement-withAngiotech Pharmaceuticals IncorporatedTue, 31 Mar 2009 20:00:31 GMThttp://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D92CREB01CAMBRIDGE, Mass. (AP) - Biotech drug developer CombinatoRx Inc. said Wednesday its second-quarter loss widened as the company spent more money to develop its drug candidates Synavive and CRx-401 and revenue decreased. For the quarter, CombinatoRx lost $17.http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D92CREB01Angiotech Pharmaceuticals IncorporatedWed, 06 Aug 2008 15:33:00 GMThttp://network.nationalpost.com/np/blogs/tradingdesk/archive/2008/05/16/activist-investor-carl-icahn-may-rekindle-yahoo-microsoft-deal.aspxFollow the markets in real time with FP Trading Desk, your up-to-the-minute look at Bay Street and beyond from Financial Posthttp://network.nationalpost.com/np/blogs/tradingdesk/archive/2008/05/16/activist-investor-carl-icahn-may-rekindle-yahoo-microsoft-deal.aspxAngiotech Pharmaceuticals IncorporatedFri, 16 May 2008 17:00:37 GMThttp://www.marketwatch.com/investing/stock/ANPIThis is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.<imghttp://www.marketwatch.com/investing/stock/ANPIAngiotech Pharmaceuticals IncorporatedMon, 17 Sep 2007 12:05:23 GMThttp://www.smartbrief.com/news/companyData.jsp?companyId=2462PRNewswire | 1 day 16 hours 6 minutes ago ...PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the beginning...mobile) Media Relations Boston Scientific Corporation Larry Neumann 508-650...office) Investor Relations Boston Scientific Corporation CONTACT: Media, Paul...http://www.smartbrief.com/news/companyData.jsp?companyId=2462Angiotech Pharmaceuticals Incorporatedhttp://topics.nytimes.com/top/news/business/companies/angiotech-pharmaceuticals-inc/index.htmlGet Home Delivery Log In Register Now Home Page My Times Today's Paper Video Most Popular Times Topics Business All NYT New York Times Business World U.S. N.Y. / Region Business Media & Advertising World Business Small Business Your Money DealBook Markets Research Mutual Funds My Portfolio Alertshttp://topics.nytimes.com/top/news/business/companies/angiotech-pharmaceuticals-inc/index.htmlAngiotech Pharmaceuticals Incorporatedhttp://www.entrepreneur.com/tradejournals/article/184746094.htmlAngiotech Pharmaceuticals, Inc., a global specialty pharmaceutical and medical device company, announced the resignation of Greg Peet from his position as a non-executive director of the company.http://www.entrepreneur.com/tradejournals/article/184746094.htmlAngiotech Pharmaceuticals Incorporatedhttp://www.holdrs.com/holdrs/main/index.asp?Action=Article&Description=&Image=&newsid={E681A770-54DD-448E-B561-811593F21B15}&symb=BSX&sid=8881VANCOUVER, Oct 10, 2008 /PRNewswire-FirstCall via COMTEX/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ GS:ANPI) , a global specialty pharmaceutical and medical device company, today reported that its corporate partner, Boston Scientific Corporation (NYSE:BSX) has received approval from the U.S.http://www.holdrs.com/holdrs/main/index.asp?Action=Article&Description=&Image=&newsid={E681A770-54DD-448E-B561-811593F21B15}&symb=BSX&sid=8881Angiotech Pharmaceuticals Incorporatedhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=ANP:CN&sid=aKyXqLbn7qwsVANCOUVER, May 8 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the Bank of America 2008 Health Care Conference, which is being held May 13-15 in Las Vegas, Nevada. Dr.http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=ANP:CN&sid=aKyXqLbn7qwsAngiotech Pharmaceuticals Incorporatedhttp://www.zibb.com/article/5612948/Angiotech+Pharmaceuticals+announces+commercial+launch+of+the+Tan+Endoglide+TM+Endothelium+Insertion+System+in+the+United+States+at+the+American+Academy+of+Ophthalmology+annual+meetingAngiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System,http://www.zibb.com/article/5612948/Angiotech+Pharmaceuticals+announces+commercial+launch+of+the+Tan+Endoglide+TM+Endothelium+Insertion+System+in+the+United+States+at+the+American+Academy+of+Ophthalmology+annual+meetingAngiotech Pharmaceuticals IncorporatedFri, 23 Oct 2009 09:00:00 GMThttp://www.prnewswire.com/news-releases/angiotech-pharmaceuticals-inc-announces-conference-call-and-webcast-63859472.htmlA live webcast of the earnings call will be available to interested parties through Angiotech's website at www.angiotech.com in the Investor Relations section.http://www.prnewswire.com/news-releases/angiotech-pharmaceuticals-inc-announces-conference-call-and-webcast-63859472.htmlAngiotech Pharmaceuticals IncorporatedFri, 09 Oct 2009 16:35:00 GMThttp://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/03-31-2009/0004997651&EDATE=/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced it has completed an Amended and Restated Distribution and License Agreement with its partner Baxter International Inc.http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/03-31-2009/0004997651&EDATE=Angiotech Pharmaceuticals IncorporatedTue, 31 Mar 2009 12:30:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=133009&full=1VANCOUVER, March 31 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. today announced it has completed an Amended and Restated Distribution and License Agreement with its partner Baxter International Inc. (Baxter). As consideration for the Amended and Restated Distribution and Licensehttp://www.biospace.com/news_story.aspx?StoryID=133009&full=1Angiotech Pharmaceuticals IncorporatedTue, 31 Mar 2009 12:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=133003&full=1VANCOUVER, March 31 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced it has completed an Amended and Restated Distribution and License Agreement with its partner Baxter International Inc. (Baxter). As consideration for the Amended and Restatedhttp://www.biospace.com/news_story.aspx?StoryID=133003&full=1Angiotech Pharmaceuticals IncorporatedTue, 31 Mar 2009 12:00:00 GMThttp://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/01-22-2008/0004740797&EDATE=angiotech.com in the Investor Relations section. A press release announcing Angiotech's financial results will be issued prior to the conference call at approximately 8:00 AM ET (5:00 AM Pacific, 6:00 AM Mountain, 7:00 AM Central).http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/01-22-2008/0004740797&EDATE=Angiotech Pharmaceuticals IncorporatedTue, 22 Jan 2008 20:05:00 GMThttp://www.zibb.com/article/5493723/Angiotech+Pharmaceuticals+Inc+ANPI+Corporate+Event+Announcement+NoticeAngiotech Pharmaceuticals, Inc. (ANPI) Expected next earnings release: Announcement date: 11/5/2009 - Before Market Earnings Quarter: Q3 Announcement Status: Unconfirmed Expected next investor conference call information: Conference Call Date: 8/6/2009 Conference Call Time (ET): 11:00 AM Conferencehttp://www.zibb.com/article/5493723/Angiotech+Pharmaceuticals+Inc+ANPI+Corporate+Event+Announcement+NoticeAngiotech Pharmaceuticals IncorporatedSat, 29 Aug 2009 20:39:18 GMThttp://www.biospace.com/news_story.aspx?StoryID=141103&full=1VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. today announced that its Quill(TM) SRS wound closure product line is now available for purchase online in the U.S. on its website at https://ecommerce.angiotech.com/Main/Home.aspx. The Quill SRS products are the firsthttp://www.biospace.com/news_story.aspx?StoryID=141103&full=1Angiotech Pharmaceuticals IncorporatedTue, 19 May 2009 12:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=104715&full=1TORONTO, July 28 (Reuters) - Angiotech Pharmaceuticals reported a wider second-quarter loss on Monday, amid falling royalty revenues for its drug-coated stents, but said it still expects to meet its full-year sales growth targets.http://www.biospace.com/news_story.aspx?StoryID=104715&full=1Angiotech Pharmaceuticals IncorporatedMon, 28 Jul 2008 12:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=93288&full=1VANCOUVER, April 21 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it has elected to suspend enrolment in its U.S. and EU human clinical trials for its Vascular Wrap producthttp://www.biospace.com/news_story.aspx?StoryID=93288&full=1Angiotech Pharmaceuticals IncorporatedMon, 21 Apr 2008 12:00:00 GMThttp://www.zibb.com/article/5581123/Angiotech+Pharmaceuticals+Inc+Announces+Conference+Call+and+WebcastAngiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) will host a conference call discussing its financial results for the third quarter ended September 30, 2009, on Monday November 9, 2009 at 11:00 AM ET (8:00 AM Pacific). Dial-in information for the earnings call on November 9, 2009 is ashttp://www.zibb.com/article/5581123/Angiotech+Pharmaceuticals+Inc+Announces+Conference+Call+and+WebcastAngiotech Pharmaceuticals IncorporatedFri, 09 Oct 2009 12:35:00 GMThttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=ANP:CN&sid=aLzVyF_STglUVANCOUVER, June 13 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced the market launch of Quill(TM) SRS MONODERM(TM).http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=ANP:CN&sid=aLzVyF_STglUAngiotech Pharmaceuticals Incorporated